Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EFFICACY OF ROFLUMILAST IN THE TREATMENT OF FLEXURAL AND/OR GENITAL PSORIASIS: A RANDOMIZED CONTROLLED TRIAL.

NCT07543640 is registered in ClinicalTrials.gov with Eman Raafat Said as lead sponsor.

NCT NCT07543640
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07543640 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EFFICACY OF ROFLUMILAST IN THE TREATMENT OF FLEXURAL AND/OR GENITAL PSORIASIS: A RANDOMIZED CONTROLLED TRIAL.
Lead sponsor
Eman Raafat Said
Phase
Phase 2
Overall status
Not yet recruiting
Start date
April 1, 2026
Completion date
August 31, 2026
Enrollment
56 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

flexural psoriasis (also known as inverse or intertriginous psoriasis) and genital psoriasis